Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Norswertianolin, a compound isolated from G. acuta, functions as a CSE activator and shows promise as a potential cardiovascular therapeutic.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 698.00 | |
10 mg | Inquiry | $ 1,120.00 |
Description | Norswertianolin, a compound isolated from G. acuta, functions as a CSE activator and shows promise as a potential cardiovascular therapeutic. |
In vitro | Norswertianolin, at concentrations ranging from 3.125 to 50 μM in H9c2 cells, exhibits protective effects against damage induced by H2O2. It notably enhances the transcription levels of HO-1 and GCLC in these cells. Additionally, when used in higher concentrations up to 150 μM in HepG2 cells, Norswertianolin significantly elevates the CSE protein level. |
In vivo | Norswertianolin, administered subcutaneously at a dosage of 4.4 mg/kg/day for one week, enhances CSE/H2S production and mitigates renal tubular injury in acute ischemia/reperfusion (I/R). Additionally, it lowers I/R-induced reactive oxygen species, as evidenced by decreased DHE fluorescence intensity. This compound also exhibits anti-hypertensive properties, prevents vascular remodeling, and diminishes inflammatory responses. These effects were observed in an animal model using male Sprague Dawley rats aged 10 to 12 weeks. |
Molecular Weight | 422.34 |
Formula | C19H18O11 |
CAS No. | 54954-12-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Norswertianolin 54954-12-0 inhibitor inhibit